106 results
10-Q/A
2013 Q2
PCSA
Processa Pharmaceuticals Inc
6 Sep 13
Quarterly report (amended)
12:00am
for the nature of an entity's business, the major products or services it sells or provides and its principal markets, including the locations of those
8-K
PCSA
Processa Pharmaceuticals Inc
21 Sep 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:29pm
, include the following changes, among others which are more administrative in nature:
Section 2.5 was amended to change the vote standard for routine
8-K
PCSA
Processa Pharmaceuticals Inc
3 Oct 19
Entry into a Material Definitive Agreement
12:00am
Subscription Agreement.
The foregoing summaries of the Line of Credit Agreements described above are summary in nature and are qualified
8-K
EX-99.1
PCSA
Processa Pharmaceuticals Inc
3 Nov 14
Separation and Severance Agreement
12:00am
understands and agrees that he is waivi ng and releasing any and all claims that he now has against the Employer regardless of their nature or origin
8-K
EX-99.1
PCSA
Processa Pharmaceuticals Inc
30 Jan 24
Processa Pharmaceuticals Announces Pricing of $7.0 Million Public Offering
10:46am
nature of the forward-looking statements include, but are not limited to, those risks and uncertainties related to market and other conditions
8-K
EX-99.2
siomzr58uugcimwyd2s
9 Jan 14
Entry into a Material Definitive Agreement
12:00am
8-K
x6k6rmj2uk
24 Mar 22
Entry into a Material Definitive Agreement
4:30pm
8-K
EX-99.1
gicha4cd w2pbkdznjps
29 Oct 14
Entry into a Material Definitive Agreement
12:00am
D
w67qfm
27 Oct 14
$6.39M in equity / options / securities to be acquired, sold $173.83K, 15 investors
12:00am
D
eyqi1yc31k9
20 Feb 15
$2M in debt, sold $90K, 3 investors
12:00am
D
p5cbujwdc
10 Jan 14
$1M in debt / options / securities to be acquired / Notes & Warrants, sold $250K, 1 investor
12:00am
D
xbbg4t
12 Jul 13
$5.4M in options / securities to be acquired / 2011 Equity Plan
12:00am
D
cj0va zl2f0kxzfx7
24 Jun 13
$4.5M in equity / options / securities to be acquired
12:00am
D
3hfkj 22gw
19 Feb 21
$10.24M in equity / options, sold $10.24M, 18 investors
9:26am
D
8f0fhb2 z58nbfwp2nkp
16 May 18
$8M in equity / options, sold $2.53M, 33 investors
10:01am
D/A
du8m bq7rg
30 Sep 13
$4.95M in equity / options / securities to be acquired, sold $2.18M, 51 investors
12:00am
8-K
EX-10.1
z9xso7s
13 Oct 20
Processa Pharmaceuticals Announces Appointment of Michael Floyd as Chief Operating Officer
9:30am
8-K
EX-10.1
etahix4
27 Aug 20
Entry into a Material Definitive Agreement
9:30am
8-K
EX-99.6
igzoxox
20 Feb 15
Senior Secured Loan Agreement
12:00am